businesspress24.com - Celsion Corporation to Hold Second Quarter 2012 Financial Results Conference Call on Tuesday, August
 

Celsion Corporation to Hold Second Quarter 2012 Financial Results Conference Call on Tuesday, August 14, 2012

ID: 1139615

(firmenpresse) - LAWRENCEVILLE, NJ -- (Marketwire) -- 08/06/12 -- Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced that it would hold a conference call to discuss second quarter 2012 results at 11:00 a.m. ET on Tuesday, August 14, 2012. To participate in the call, interested parties may dial 1-888-504-7965 (Toll-Free/North America) or 1-719-325-2493 (International/Toll) and ask for the Celsion Corporation Second Quarter 2012 Earnings Conference Call approximately ten minutes before the call is scheduled to begin. The call will also be broadcast live on the internet at .

The call will be archived for replay on Tuesday, August 14, 2012 at 2:00 p.m. ET and will remain available until Tuesday, August 28, 2012. The replay can be accessed at 1-877-870-5176 (Toll-Free/North America) or 1-858-384-5517 (International/Toll) using Conference ID: 8709649. An audio replay of the call will also be available on the Company's website, , for 30 days after 2:00 p.m. ET on Tuesday, August 14, 2012.



Celsion is a leading oncology company dedicated to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated liposomal drug technology. Celsion has research, license, or commercialization agreements with leading institutions including the National Institutes of Health, Duke University Medical Center, University of Hong Kong, the University of Pisa, the UCLA Department of Medicine, Kyungpook National University Hospital and the Beijing Cancer Hospital.

For more information on Celsion, visit our website: .



David Pitts
Argot Partners
212-600-1902




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Bioheart Renegotiates Company Note With Favorable Terms
TNI BioTech, Inc., in Partnership With GB Oncology and Imaging Group LTD., Signs Agreement With the Republic of Malawi
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 06.08.2012 - 07:05 Uhr
Sprache: Deutsch
News-ID 1139615
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

LAWRENCEVILLE, NJ


Phone:

Kategorie:

Surgery & Treatments


Anmerkungen:


Diese Pressemitteilung wurde bisher 196 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Celsion Corporation to Hold Second Quarter 2012 Financial Results Conference Call on Tuesday, August 14, 2012
"
steht unter der journalistisch-redaktionellen Verantwortung von

Celsion Corporation (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Celsion Corporation



 

Who is online

All members: 10 563
Register today: 2
Register yesterday: 2
Members online: 0
Guests online: 112


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.